 |
 |
 |
 |
 |
 |
 |
|
 |
 |
|
|
|
Our executive team at Genemed Biotechnologies, Inc. has over 100 years of combined management experience in the development and manufacture of biological and diagnostic products. Their areas of expertise include manufacturing and technical operations, quality control and quality assurance, R&D, validation, and business development.
Our Vision: To lead by example, model ethical behavior, facilitate trust between managers and employees, and to provide a work environment that fosters open and honest communication, creative thinking, and cross-functional collaboration.
Our Mission: To expand the knowledge and capabilities of our employees through training and coaching, and to provide a safe, comfortable, and productive work environment.
Our Values: - Accountability
- Trust
- Ethics
- Fair
- Motivation
- Challenge
- Knowledge
Key members of our executive team include:
 |
CEO and Chairman
Dr. Tsao founded Genemed Biotechnologies, Inc. in 1987.
Prior to his position at Genemed Biotechnologies Inc., Dr. Tsao was also the founder and President of Zymed Laboratories and Genemed Synthesis Inc. Zymed Laboratories, founded in 1980, provided antibody based immunochemicals for cancer research and cancer diagnostic applications. The company was acquired by Invitrogen in 2005. Genemed Synthesis Inc, founded in 1995, provided custom DNA and Peptides synthesis services. The company was acquired by Genomic Resources Inc. in 2007.
During the late 80s and early 90s, Dr. Tsao was a visiting professor at the Chinese Academy of Preventative Medicine, Beijing, adjunct professor at Chang Gung Medical College, and visiting scientist at Veterans General Hospital, Taiwan.
Dr. Tsao holds a doctorate in biochemistry from Colorado State University and a B.S. in Agricultural Chemistry from National Chung-Hsing University, Taiwan. He has authored more than thirty scientific articles and three patents and has been honored with the American Heart Association Post-Doctorate Fellowship. He also served in College of Natural Sciences External Advisory Committee of CSU. |
 |
President
Peter has over 20 years of management expertise in the biotechnologies and medical device industries, with a degree from U.C. Berkeley. |
 |
Director of IHC
Rina has over 10 years of experience in design and development immunohistochemistry (IHC) assays, in situ hybridization (ISH) assays in single and multiplexed, manual and automated platforms. She has both a M.D. and Ph. D. with numerous publications and a patent on CISH. |
 |
CFO
William has over 13 years of accounting experience in various industries in addition to many years of experience in HR and Benefit administration. He received his MBA in Accounting from Golden Gate University and passed the CPA exam at the same time. |
 |
QA Manager
Lynda has over 30 years of experience in Quality Control and Quality Assurance, both in the food and medical device industries. She graduated with a BA from CSULA, with a major in physical science and consumer affairs. |
 |
Director of Positive Controls
Robert has many years of management and medical device industry experience, with a degree from University of San Francisco. |
|
|
|
|
 |
 |
|
 |
 |
 |
 |
|
 |
 |
|
|
|
